CS
IMGN

Candriam SCA’s Immunogen Inc IMGN Stock Holding History

Candriam SCA’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,122,598
Closed -$33.3M – 749
2023
Q4 		$33.3M Buy
1,122,598
+10
+0% +$199 0.23% 99
2023
Q3 		$17.8M Buy
1,122,588
+130,006
+13% +$2.16M 0.13% 159
2023
Q2 		$18.7M Sell
992,582
-1,396,714
-58% -$16.5M 0.14% 169
2023
Q1 		$8.44M Sell
2,389,296
-300,000
-11% -$1.28M 0.06% 278
2022
Q4 		$13.3M Sell
2,689,296
-165,339
-6% -$896K 0.09% 218
2022
Q3 		$13.6M Buy
2,854,635
+1,798,196
+170% +$9.48M 0.1% 213
2022
Q2 		$4.75M Buy
+1,056,439
New +$4.59M 0.04% 329
2021
Q4 		– Sell
-2,562,935
Closed -$14.5M – 881
2021
Q3 		$14.5M Buy
2,562,935
+101,476
+4% +$586K 0.1% 220
2021
Q2 		$16.2M Buy
+2,461,459
New +$17.2M 0.11% 218
2019
Q3 		– Sell
-579,210
Closed -$1.25M – 824
2019
Q2 		$1.25M Sell
579,210
-575,511
-50% -$1.36M 0.02% 611
2019
Q1 		$3.13M Buy
1,154,721
+133,582
+13% +$579K 0.04% 409
2018
Q4 		$4.9M Buy
1,021,139
+68,639
+7% +$416K 0.08% 285
2018
Q3 		$9.02M Buy
952,500
+258,500
+37% +$2.48M 0.12% 205
2018
Q2 		$6.75M Buy
694,000
+100,000
+17% +$1.05M 0.11% 242
2018
Q1 		$6.25M Buy
594,000
+24,000
+4% +$237K 0.11% 243
2017
Q4 		$3.65M Hold
570,000
– – 0.06% 330
2017
Q3 		$4.36M Hold
570,000
– – 0.08% 291
2017
Q2 		$4.05M Buy
+570,000
New +$2.61M 0.08% 307
2016
Q2 		– Sell
-208,000
Closed -$1.76M – 683
2016
Q1 		$1.76M Sell
208,000
-30,100
-13% -$255K 0.04% 343
2015
Q4 		$3.23M Hold
238,100
– – 0.09% 240
2015
Q3 		$2.29M Sell
238,100
-61,900
-21% -$905K 0.06% 317
2015
Q2 		$4.31M Sell
300,000
-60,000
-17% -$659K 0.09% 261
2015
Q1 		$3.22M Sell
360,000
-125,000
-26% -$905K 0.06% 323
2014
Q4 		$2.96M Buy
+485,000
New +$4.44M 0.06% 309

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Candriam SCA's IMGN Position: Q1 2024 in Review

Candriam SCA sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,122,598 shares — an estimated $33.3M sold.

Candriam SCA first reported a position in IMGN in Q4 2014 and held it in 24 quarters. The position peaked at $33.3M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Candriam SCA reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Candriam SCA sold 1,122,598 Immunogen Inc shares in Q1 2024, an estimated $33.3M.
  • Candriam SCA first reported a position in Immunogen Inc in Q4 2014 and held it in 24 quarters.
  • Candriam SCA's Immunogen Inc position peaked at $33.3M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.